- Patent Title: 52-gene signature in peripheral blood identifies a genomic profile associated with increased risk of mortality and poor disease outcomes in idiopathic pulmonary fibrosis
-
Application No.: US15727482Application Date: 2017-10-06
-
Publication No.: US10896740B2Publication Date: 2021-01-19
- Inventor: Naftali Kaminski , Jose D. Herazo-Maya
- Applicant: Yale University
- Applicant Address: US CT New Haven
- Assignee: Yale University
- Current Assignee: Yale University
- Current Assignee Address: US CT New Haven
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: G16B20/00
- IPC: G16B20/00 ; C12Q1/6883 ; C40B30/06 ; C12N15/10 ; G16B25/00
Abstract:
The clinical course of idiopathic pulmonary fibrosis (IPF) is difficult to predict. Described herein is a peripheral blood 52-gene expression signature useful to improve outcome prediction in IPF.
Public/Granted literature
Information query
